Solventum (NYSE:SOLV) Hits New 12-Month High – What’s Next?

Solventum Corporation (NYSE:SOLV)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $88.24 and last traded at $88.2450, with a volume of 667273 shares trading hands. The stock had previously closed at $86.17.

Analyst Ratings Changes

A number of brokerages recently issued reports on SOLV. Stifel Nicolaus decreased their price objective on Solventum from $105.00 to $90.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. Wedbush began coverage on shares of Solventum in a research note on Friday, May 15th. They set an “outperform” rating and a $94.00 price objective on the stock. Wells Fargo & Company decreased their target price on shares of Solventum from $83.00 to $70.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 6th. BTIG Research restated a “buy” rating and set a $91.00 price target on shares of Solventum in a research report on Monday, July 13th. Finally, BMO Capital Markets began coverage on shares of Solventum in a report on Wednesday, July 8th. They issued a “market perform” rating and a $81.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Solventum presently has a consensus rating of “Hold” and a consensus target price of $86.00.

Solventum Stock Down 1.8%

The company has a quick ratio of 0.75, a current ratio of 1.07 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $15.06 billion, a PE ratio of 10.66, a price-to-earnings-growth ratio of 1.37 and a beta of 0.66. The business’s 50 day simple moving average is $78.24 and its 200 day simple moving average is $74.20.

Solventum (NYSE:SOLV) last announced its earnings results on Tuesday, May 5th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.35 by $0.13. Solventum had a net margin of 17.33% and a return on equity of 23.51%. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period last year, the company posted $1.34 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. As a group, analysts forecast that Solventum Corporation will post 6.58 EPS for the current year.

Hedge Funds Weigh In On Solventum

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. United Services Automobile Association acquired a new stake in shares of Solventum in the first quarter worth $239,000. Woodline Partners LP raised its position in Solventum by 40.7% during the first quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock valued at $888,000 after buying an additional 3,377 shares during the period. Intech Investment Management LLC lifted its stake in Solventum by 167.0% in the 1st quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock worth $1,268,000 after acquiring an additional 10,425 shares in the last quarter. First Trust Advisors LP lifted its stake in Solventum by 5.8% in the 2nd quarter. First Trust Advisors LP now owns 257,727 shares of the company’s stock worth $19,546,000 after acquiring an additional 14,151 shares in the last quarter. Finally, Marshall Wace LLP acquired a new stake in Solventum during the 2nd quarter worth about $766,000.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.